Inhibition of endogenous PTK7 signaling in highly invasive BC cells with TNBC characteristics by a dominant negative mutant or siRNA silencing results in loss of the capacity to invade the surrounding matrix and to migrate into the wound area. The gene discussed is PTK7; the disease is breast cancer.